Gopi Patel
Family Medicine · Jackson, NJNPI 1720495245
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 37.3% of the total. Reporting peaked in 2019 at $847 and has fallen 95.8% since, to $36 in 2024.
Across 188 payments — averaging $14.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$350
- Pfizer$248
- Boehringer Ingelheim$171
- Amarin Pharma, Inc.$159
- Merck$115
- plus $666 from 16 others
What the payments were for
- Food & beverage$2,726100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 79 | $1,016 |
| Lilly USA, LLC | 24 | $350 |
| Pfizer | 8 | $248 |
| Boehringer Ingelheim | 12 | $171 |
| Amarin Pharma, Inc. | 12 | $159 |
| Merck | 8 | $115 |
| Sanofi-aventis U.S. LLC | 7 | $100 |
| AstraZeneca | 6 | $85 |
| Amgen | 6 | $85 |
| Johnson & Johnson | 5 | $70 |
| Teva Pharmaceuticals USA, Inc. | 5 | $61 |
| Boston Scientific | 2 | $50 |
| Exact Sciences | 2 | $45 |
| Genentech USA, Inc. | 3 | $40 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Abbott | 1 | $20 |
| Bayer | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAXLOVID$133
How this compares
$2,726 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 103 | $1,581 |
| SynthroidLevothyroxine Sodium | 18 | $1,371 |
| Levothyroxine Sodium | 47 | $960 |
| Atorvastatin Calcium | 81 | $828 |
| Amlodipine Besylate | 71 | $600 |
| Escitalopram Oxalate | 22 | $533 |
| Omeprazole | 23 | $452 |
| Metoprolol Succinate | 27 | $410 |
| Losartan Potassium | 22 | $391 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $325 |
| Pantoprazole Sodium | 18 | $233 |
| Lisinopril | 32 | $230 |
| Sertraline Hcl | 11 | $221 |
| Zolpidem Tartrate | 22 | $212 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 13 | $174 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Jackson
- Mikhail VarshavskiChatham$1.4M
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
- Jennifer CaudleSewell$226K
- Jeffrey LevineNew Brunswick$195K
- Jennifer AmicoNew Brunswick$159K
- Dena LacaraFairfield$122K
- Gaurang BrahmbhattHoboken$89K
- Juan LatorreHoboken$71K
- Sally MravcakJersey City$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.